Melanoma Foundation of New England Company Profile

06:15 EST 22nd November 2017 | BioPortfolio

News Articles [1298 Associated News Articles listed on BioPortfolio]

The “Great Dental Divide” between north and south England

According to a latest report published by the Nuffield Trust and the Health Foundation, the percentages of people with good dental health varies vastly between northern and southern England.

Early Stage Melanoma Identified by Simple Blood Test

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes....

Link established between a molecular driver of melanoma, novel therapeutic agent

Scientists have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced melanoma, providing useful infor...

Combination targeted adjuvant therapy doubles relapse-free survival in stage III melanoma

(European Society for Medical Oncology) Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage III BRAF-mutant melanoma, according to...

Waiting Even a Month to Remove Melanoma Can Be Deadly

TUESDAY, Nov. 7, 2017 -- The sooner the deadly skin cancer melanoma is treated, the more likely a patient is to survive. Researchers analyzed data from more than 153,000 American adults diagnosed with...

CMA clears Birmingham hospitals merger

The Competition and Markets Authority has cleared a merger between Heart of England NHS Foundation Trust (HEFT) and University Hospitals Birmingham NHS Foundation Trust (UHB).

A New Method of Combating MAPK Inhibitor-Resistant Melanoma

Researchers have found that melanoma patients may benefit from a holiday from MAPK inhibitors while alternative therapies stave off emergence of resistant melanoma clones.

This diagnostic device uses temperature to aid melanoma detection

Four recent engineering graduates from McMaster University, near Toronto, built a device to detect melanoma that measures the temperature differences between melanoma and normal tissue.

Drugs and Medications [472 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [2262 Associated PubMed Articles listed on BioPortfolio]

The academic foundation programme: a new foundation for academic medicine.

Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema.

To explore health-related quality of life (HRQoL) in recurrence-free melanoma patients, with a focus on the association between melanoma-related limb lymphoedema and HRQoL.

Synchronous conjunctival melanoma and lentigo maligna melanoma.

Lentigo maligna has an extensive and neoplastic character. It typically progresses slowly and may eventually develop into an invasive melanoma, which is called lentigo maligna melanoma. Ocular melanom...

Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma.

Ipilimumab is approved for the treatment of advanced melanoma in adults; however, little information on the efficacy and safety of ipilimumab in younger patients is available.

Palmar melanoma: A tertiary centre experience.

Acral melanoma is the most common subtype of melanoma in darker-pigmented individuals, and recent studies report that acral melanoma shows unique behaviours compared to other subtypes.(1) Previous rep...

Clinical Trials [1334 Associated Clinical Trials listed on BioPortfolio]

A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab

Participants with advanced or metastatic mucosal melanoma (cohort A) and acral lentiginous melanoma (cohort B) eligible for treatment with nivolumab in combination with ipilimumab followed...

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. It is not yet known whether combining melanoma vaccine with interleukin-2 is more effective than vaccine...

Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns

The purpose of this study is to examine the health behaviors of melanoma survivors. We want to know about their thoughts and concerns. Melanoma is a type of skin cancer. The number of peop...

Vaccination Plus Ontak in Patients With Metastatic Melanoma

The purpose of this study is to determine if an experimental melanoma vaccine can produce an immune response in patients with metastatic melanoma, and if combining this vaccine with the d...

Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients

This phase I/II study is directed at evaluating safety and immunogenicity of a melanoma peptide vaccine in combination or not with Dacarbazine administration in melanoma patients

Companies [1618 Associated Companies listed on BioPortfolio]

AIM at Melanoma

AIM at Melanoma, founded in memory of Charlie Guild, who died of melanoma at the age of 26, is the largest international melanoma foundation focused on melanoma research, patient ...

Melanoma Foundation of New England

Polynoma LLC

Malignant melanoma is the most serious form of skin cancer. An estimated 200,000 new cases of melanoma are diagnosed annually around the world, with about 76,000 in the United Sta...

Melanoma Research Foundation

Mollie Biggane Melanoma Foundation

More Information about "Melanoma Foundation of New England" on BioPortfolio

We have published hundreds of Melanoma Foundation of New England news stories on BioPortfolio along with dozens of Melanoma Foundation of New England Clinical Trials and PubMed Articles about Melanoma Foundation of New England for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Melanoma Foundation of New England Companies in our database. You can also find out about relevant Melanoma Foundation of New England Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record